AFP and hepatocellular carcinoma: Combinatorial strategies for the surveillance and diagnosis of HCC, exemplified by the GALAD and HES algorithms, which incorporate AFP alongside additional biomarkers, have shown considerable promise following rigorous phase 3 prospective validations.